Phase 0 1 trial
Phase 0
NCT03627520 Apr → Jul 2018 —
Hutchison Medipharma Limited
Completed
No outcome recorded
Phase 1 11 trials
Phase 1
NCT04755075 Feb → Oct 2021 —
Hutchison Medipharma Limited
Completed
No outcome recorded
Phase 1
NCT04755088 Feb → Aug 2021 impaired renal function disease Hutchison Medipharma Limited
Completed
No outcome recorded
Phase 1
NCT04372394 Aug → Oct 2020 —
Hutchison Medipharma Limited
Completed
No outcome recorded
Phase 1
NCT04510649 Jul → Sep 2020 —
Hutchison Medipharma Limited
Completed
No outcome recorded
Phase 1
NCT04372407 Jul → Sep 2020 —
Hutchison Medipharma Limited
Completed
No outcome recorded
Phase 1
NCT04427774 Jun 2020 → Feb 2021 —
Innovent Biologics (Suzhou) Co. Ltd.
Terminated
No outcome recorded
Phase 1
NCT03879057 Dec 2018 → Dec 2020 neoplasm Peking University
Unknown
No outcome recorded
Phase 1
NCT03483259 Apr → May 2018 —
Hutchison Medipharma Limited
Completed
No outcome recorded
Phase 1
NCT02320409 Dec 2014 → Jan 2015 —
Hutchison Medipharma Limited
Completed
No outcome recorded
Phase 1
NCT02267967 Oct 2014 → Aug 2017 neuroendocrine neoplasm Hutchison Medipharma Limited
Completed
No outcome recorded
Phase 1
NCT02133157 Apr 2010 → Oct 2014 neoplasm Hutchison Medipharma Limited
Completed
No outcome recorded
Show 1 more trial Phase 1/2 16 trials
Phase 1/2
NCT06255262 Feb 2024 → Oct 2025 biliary tract cancer China Medical University, China
Unknown
No outcome recorded
Phase 1/2
NCT05832892 Nov 2023 → Nov 2024 neoplastic disease or syndrome Shanghai Zhongshan Hospital
Unknown
No outcome recorded
Phase 1/2
NCT06038461 Sep 2023 → Sep 2026 expected neuroendocrine neoplasm Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Recruiting
No outcome recorded
Phase 1/2
NCT05747729 Jun 2023 → Oct 2026 expected neuroendocrine carcinoma Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Recruiting
No outcome recorded
Phase 1/2
NCT05882630 Jun 2023 → Jun 2025 small cell lung carcinoma Fujian Cancer Hospital
Unknown
No outcome recorded
Phase 1/2
NCT05746728 Apr 2023 → Aug 2024 triple-negative breast carcinoma Huihua Xiong
Unknown
No outcome recorded
Phase 1/2
NCT05590572 Jan 2023 → Dec 2026 expected osteosarcoma Second Affiliated Hospital, School of Medicine, Zhejiang University
Not yet recruiting
No outcome recorded
Phase 1/2
NCT05494580 Sep 2022 → Jun 2024 fallopian tube carcinosarcoma , ovarian carcinoma , primary peritoneal carcinoma Sun Yat-sen University
Completed
No outcome recorded
Phase 1/2
NCT05839275 Aug 2022 → Jul 2024 overdue soft tissue sarcoma Fudan University
Recruiting
No outcome recorded
Phase 1/2
NCT05093322 Nov 2021 → Apr 2023 Ewing sarcoma , lymphoma , osteosarcoma , rhabdomyosarcoma Hutchmed
Completed
No outcome recorded
Phase 1/2
NCT04996771 Nov 2021 → Dec 2023 small cell lung carcinoma Sun Yat-sen University
Unknown
No outcome recorded
Phase 1/2
NCT05077384 Sep 2021 → Sep 2024 cancer-related condition , neuroendocrine neoplasm Hutchmed
Completed
No outcome recorded
Phase 1/2
NCT05218889 Aug 2021 → Dec 2024 overdue pancreatic ductal adenocarcinoma Chinese PLA General Hospital
Recruiting
No outcome recorded
Phase 1/2
NCT04929652 Jun 2021 → Jun 2022 colorectal cancer Jiangsu Cancer Institute & Hospital
Unknown
No outcome recorded
Phase 1/2
NCT04579757 Mar 2021 → Apr 2024 colorectal cancer , gastric cancer , metastatic neoplasm , small cell lung carcinoma +2 Hutchmed
Terminated
No outcome recorded
Phase 1/2
NCT02549937 Nov 2015 → Apr 2023 neoplasm Hutchmed
Completed
No outcome recorded
Show 6 more trials Phase 2 62 trials
Phase 2
NCT07609121 Jun 2026 → May 2029 expected non-small cell lung carcinoma Sun Yat-sen University
Recruiting
No outcome recorded
Phase 2
NCT07469956 Mar 2026 → Jan 2028 expected pancreas disorder Sun Yat-sen University
Not yet recruiting
No outcome recorded
Phase 2
NCT07279532 Jan 2026 → Dec 2029 expected neuroendocrine neoplasm Second Affiliated Hospital, School of Medicine, Zhejiang University
Not yet recruiting
No outcome recorded
Phase 2
NCT07103395 Jan 2026 → Dec 2029 expected non-small cell lung carcinoma Sun Yat-sen University
Recruiting
No outcome recorded
Phase 2
NCT07156019 Oct 2025 → Dec 2026 expected neuroendocrine carcinoma Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not yet recruiting
No outcome recorded
Phase 2
NCT07357623 Sep 2025 → Sep 2027 expected lung neuroendocrine neoplasm Shanghai Chest Hospital
Recruiting
No outcome recorded
Phase 2
NCT07086469 Jul 2025 → Jul 2029 expected esophageal squamous cell carcinoma Sun Yat-sen University
Recruiting
No outcome recorded
Phase 2
NCT07086456 Jul 2025 → Jul 2029 expected non-small cell lung carcinoma Sun Yat-sen University
Recruiting
No outcome recorded
Phase 2
NCT06654947 Jan 2025 → Dec 2026 expected biliary tract cancer Fujian Cancer Hospital
Not yet recruiting
No outcome recorded
Phase 2
NCT06876844 Dec 2024 → Sep 2027 expected head and neck squamous cell carcinoma Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Recruiting
No outcome recorded
Phase 2
NCT06719700 Nov 2024 → Nov 2028 expected small cell lung carcinoma Sun Yat-sen University
Recruiting
No outcome recorded
Phase 2
NCT06656559 Oct 2024 → Sep 2025 overdue biliary tract cancer Tianjin Medical University Cancer Institute and Hospital
Not yet recruiting
No outcome recorded
Phase 2
NCT06708858 Aug 2024 → Dec 2025 overdue biliary tract cancer Dai, Guanghai
Recruiting
No outcome recorded
Phase 2
NCT06531291 Aug 2024 → Aug 2027 expected biliary tract cancer , esophageal squamous cell carcinoma , gastric cancer , malignant pancreatic neoplasm RenJi Hospital
Not yet recruiting
No outcome recorded
Phase 2
NCT06447636 Aug 2024 → Aug 2025 overdue gastric cancer , gastroesophageal junction adenocarcinoma Fudan University
Not yet recruiting
No outcome recorded
Phase 2
NCT06158516 Jun 2024 → Jun 2026 pancreatic neuroendocrine tumor Changhai Hospital
Terminated
No outcome recorded
Phase 2
NCT06414915 Jun 2024 → Jun 2026 overdue non-small cell lung carcinoma National Cancer Center, China
Not yet recruiting
No outcome recorded
Phase 2
NCT06361030 Jun 2024 → Jun 2026 overdue pancreatic ductal adenocarcinoma Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not yet recruiting
No outcome recorded
Phase 2
NCT06437353 May 2024 → Oct 2025 overdue ovarian cancer Anhui Provincial Cancer Hospital
Recruiting
No outcome recorded
Phase 2
NCT06329947 May 2024 → Jan 2025 overdue malignant pancreatic neoplasm Rui-hua Xu, MD, PhD
Not yet recruiting
No outcome recorded
Phase 2
NCT06375642 May 2024 → Aug 2025 overdue intrahepatic cholangiocarcinoma Tianjin Medical University Cancer Institute and Hospital
Not yet recruiting
No outcome recorded
Phase 2
NCT06199882 Feb 2024 → Jun 2025 biliary tract cancer Zhejiang Cancer Hospital
Suspended
No outcome recorded
Phase 2
NCT05926492 Jan 2024 → Jul 2025 overdue osteosarcoma Second Affiliated Hospital, School of Medicine, Zhejiang University
Recruiting
No outcome recorded
Phase 2
NCT05969171 Dec 2023 → Dec 2026 expected malignant pancreatic neoplasm Fudan University
Recruiting
No outcome recorded
Phase 2
NCT06134193 Nov 2023 → Jun 2024 gallbladder cancer , intrahepatic cholangiocarcinoma Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Unknown
No outcome recorded
Phase 2
NCT06092645 Oct 2023 → Oct 2024 bile duct adenocarcinoma Zhejiang Cancer Hospital
Unknown
No outcome recorded
Phase 2
NCT05988372 Oct 2023 overdue pancreatic exocrine neoplasm Sun Yat-sen University
Not yet recruiting
No outcome recorded
Phase 2
NCT06062485 Oct 2023 → Oct 2025 overdue carcinoma of the ampulla of vater The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not yet recruiting
No outcome recorded
Phase 2
NCT05989425 Aug 2023 → Aug 2026 overdue differentiated thyroid carcinoma Fudan University
Recruiting
No outcome recorded
Phase 2
NCT05908747 May 2023 → May 2025 malignant pancreatic neoplasm Tianjin Medical University Cancer Institute and Hospital
Completed
No outcome recorded
Phase 2
NCT05722977 Feb 2023 → Feb 2026 overdue —
Peking Union Medical College Hospital
Not yet recruiting
No outcome recorded
Phase 2
NCT05472948 Feb 2023 → Dec 2027 expected appendix carcinoma , metastatic malignant neoplasm , small intestine adenocarcinoma Sun Yat-sen University
Recruiting
No outcome recorded
Phase 2
NCT05481463 Jan 2023 → Mar 2025 malignant pancreatic neoplasm Sun Yat-sen University
Completed
No outcome recorded
Phase 2
NCT05481476 Dec 2022 → Dec 2025 overdue malignant pancreatic neoplasm Sun Yat-sen University
Active not recruiting
No outcome recorded
Phase 2
NCT05595889 Dec 2022 → Sep 2024 chemotherapy-induced toxicity , small cell lung carcinoma Fujian Cancer Hospital
Unknown
No outcome recorded
Phase 2
NCT05668767 Dec 2022 → Dec 2023 small cell lung carcinoma Beijing Chest Hospital
Unknown
No outcome recorded
Phase 2
NCT05652283 Nov 2022 → May 2024 overdue ovarian cancer Bai-Rong Xia
Active not recruiting
No outcome recorded
Phase 2
NCT05527821 Sep 2022 → Sep 2024 cancer of unknown primary site , carcinoma Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Unknown
No outcome recorded
Phase 2
NCT06239532 Sep 2022 → Dec 2024 overdue intrahepatic cholangiocarcinoma Qilu Hospital of Shandong University
Active not recruiting
No outcome recorded
Phase 2
NCT05509699 Sep 2022 → Jul 2024 small cell lung carcinoma Hutchison Medipharma Limited
Completed
No outcome recorded
Phase 2
NCT05235906 Aug 2022 → Mar 2024 gastric adenocarcinoma Sun Yat-sen University
Unknown
No outcome recorded
Phase 2
NCT05165407 Jul 2022 → Sep 2025 overdue neuroendocrine neoplasm Peking University
Recruiting
No outcome recorded
Phase 2
NCT05627427 Jul 2022 → Apr 2024 neuroendocrine carcinoma Tianjin Medical University Cancer Institute and Hospital
Unknown
No outcome recorded
Phase 2
NCT05186545 Jul 2022 → Jan 2024 female breast carcinoma The First Affiliated Hospital of Zhengzhou University
Unknown
No outcome recorded
Phase 2
NCT05282433 Apr 2022 → Dec 2023 hepatocellular carcinoma Zhongnan Hospital
Unknown
No outcome recorded
Phase 2
NCT05372198 Mar 2022 → Jan 2024 colorectal neoplasm Hubei Cancer Hospital
Unknown
No outcome recorded
Phase 2
NCT05171439 Mar → Sep 2022 hepatocellular carcinoma The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Unknown
No outcome recorded
Phase 2
NCT05236699 Feb 2022 → Jun 2024 intrahepatic cholangiocarcinoma Tongji Hospital
Completed
No outcome recorded
Phase 2
NCT05003037 Jan 2022 → Nov 2025 overdue non-small cell lung carcinoma Li Zhang, MD
Active not recruiting
No outcome recorded
Phase 2
NCT05106777 Dec 2021 → Dec 2025 overdue sarcoma Sun Yat-sen University
Active not recruiting
No outcome recorded
Phase 2
NCT04764006 Oct 2021 → Oct 2022 colorectal cancer Fujian Cancer Hospital
Unknown
No outcome recorded
Phase 2
NCT04579679 Aug 2021 → Sep 2024 lung neuroendocrine neoplasm , small intestine neuroendocrine neoplasm Hutchmed
Terminated
No outcome recorded
Phase 2
NCT04955886 Aug 2021 → Aug 2022 nasopharyngeal carcinoma Fujian Cancer Hospital
Unknown
No outcome recorded
Phase 2
NCT05030246 Jul 2021 → Apr 2023 digestive system carcinoma , primary peritoneal carcinoma Peking University
Unknown
No outcome recorded
Phase 2
NCT04910854 May 2021 → Mar 2022 salivary gland cancer Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Unknown
No outcome recorded
Phase 2
NCT04734249 Mar 2021 colorectal cancer Fujian Cancer Hospital
Unknown
No outcome recorded
Phase 2
NCT04653480 Feb 2021 → Jun 2025 colorectal cancer Zhejiang University
Unknown
No outcome recorded
Phase 2
NCT04524884 Oct 2020 → Apr 2022 thyroid cancer Fudan University
Unknown
No outcome recorded
Phase 2
NCT04922658 Jun 2020 → Dec 2025 overdue non-small cell lung carcinoma Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Active not recruiting
No outcome recorded
Phase 2
NCT04169672 Dec 2019 → Feb 2023 cancer Hutchison Medipharma Limited
Completed
No outcome recorded
Phase 2
NCT02966821 Jan 2017 → Aug 2018 biliary tract cancer Hutchison Medipharma Limited
Completed
No outcome recorded
Phase 2
NCT02614495 Feb 2016 → Sep 2018 thyroid gland carcinoma Hutchison Medipharma Limited
Completed
No outcome recorded
Show 52 more trials Phase 2/3 2 trials
Phase 2/3
NCT06361888 May 2024 → May 2028 expected malignant pancreatic neoplasm Hutchmed
Recruiting
No outcome recorded
Phase 2/3
NCT03873532 Jul 2018 → Jun 2021 biliary tract cancer Hutchison Medipharma Limited
Unknown
No outcome recorded
Phase 3 3 trials
Phase 3
NCT07436741 Mar 2026 → Sep 2028 expected malignant pancreatic neoplasm Tianjin Medical University Cancer Institute and Hospital
Recruiting
No outcome recorded
Phase 3
NCT02589821 Dec 2015 → Nov 2019 pancreatic neuroendocrine tumor Hutchison Medipharma Limited
Completed
No outcome recorded
Phase 3
NCT02588170 Dec 2015 → Mar 2019 neuroendocrine neoplasm Hutchison Medipharma Limited
Completed
No outcome recorded
Phase 4 1 trial
Phase 4
NCT07272512 Nov 2025 → Nov 2027 expected neuroendocrine neoplasm Shanghai Zhongshan Hospital
Recruiting
No outcome recorded
Phase not applicable 5 trials
— NCT06313554 May 2024 overdue intrahepatic cholangiocarcinoma Fudan University
Not yet recruiting
No outcome recorded
— NCT06156332 Jan 2024 → Jan 2025 overdue neuroendocrine neoplasm Shanghai Changzheng Hospital
Not yet recruiting
No outcome recorded
— NCT06110650 Nov 2023 → Aug 2024 soft tissue sarcoma Fudan University
Unknown
No outcome recorded
— NCT05056116 Sep 2021 → Jun 2022 biliary tract cancer The Affiliated Hospital of Xuzhou Medical University
Unknown
No outcome recorded
— NCT05013515 Aug 2021 → Sep 2022 salivary gland carcinoma Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Unknown
No outcome recorded
Phase not stated 1 trial
— NCT04814732 — neuroendocrine neoplasm Hutchmed
No longer available
No outcome recorded